Mercedes Porosnicu MD
Professor of Internal Medicine, Section on Hematology and Oncology Wake Forest School of Medicine
Join to view full profile
S Hawthorne RdWinston-Salem, NC 27157
Phone+1 336-716-2255
Dr. Porosnicu is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 1998 - 2001
SUNY Downstate Health Sciences UniversityResidency, Internal Medicine, 1996 - 1998
University of Medicine and Pharmacy ‘Gr T Popa” Iasi Class of 1987
Certifications & Licensure
NC State Medical License 2006 - 2027
FL State Medical License 2002 - 2008
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
Clinical Trials
- Intensity-Modulated Radiation Therapy, Pemetrexed, and Erlotinib in Treating Patients With Recurrent or Second Primary Head and Neck Cancer
- Erlotinib and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed by Surgery
- Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
Publications & Presentations
PubMed
- Pembrolizumab Plus Quad-Shot Radiotherapy for Recurrent, Unresectable, or Metastatic Head and Neck Cancer: A Nonrandomized Clinical Trial.Ryan T Hughes, Sydney Smith, Thomas W Lycan Jr, Paul M Bunch, Ralph B D'Agostino Jr
JAMA Otolaryngology-- Head & Neck Surgery. 2026-08-01 - Survival and Quality of Life After Reirradiation With Concurrent Pemetrexed/Erlotinib Followed by Maintenance Erlotinib for Recurrent/Second Primary Head and Neck Squa...Ryan T Hughes, Sydney Smith, D Neil Hayes, Bhishamjit Chera, Ralph B D'Agostino Jr
Cureus. 2026-04-01 - 1 citationsMutational Profile of Blood and Tumor Tissue and Biomarkers of Response to PD-1 Inhibitors in Patients with Cutaneous Squamous Cell Carcinoma.Mark J Chang, Daniel B Stamos, Cetin Urtis, Nathan L Bowers, Lauren M Schmalz
Cancers. 2025-03-31
Abstracts/Posters
- Retrospective Analysis of Cisplatin Nephrotoxicity in Head and Neck Cancer Patients Treated as Outpatient with Concurrent High-Dose Cisplatin and RadiotherapyM. Haughton, MD, J. Faig, M, R. B. D'Agostino, PhD, M. J. Whelan, MPH, M. Murea, MD, M. Porosnicu, MD, Multidisciplinary Head and Neck Symposium, 1/1/2014
- Phase I Clinical Trial of Re-irradiation with Pemetrexed and Erlotinib followed by Maintenance Erlotinib for Recurrent and Second Primary Squamous Cell Carcinoma of th...M. Porosnicu, MD, K. Greven, MD, N. Hayes, MD, B. Chera, MD, C. Sullivan, MD, J. D. Waltonen, MD, J. D. Browne, MD, Multidisciplinary Head and Neck Symposium, 1/1/2014
- Retrospective Analysis of the Impact of HPV Status and Smoking on Mucositis in Patients with Oropharyngeal Squamous Cell Carcinoma Treated with Concurrent Chemotherapy...M. Porosnicu, MD, M. Vatca, MD; J.T. Lucas, Jr., MS, MD, J. Laudadio, MD; R.B. D’Agostino, Jr., PhD; J.D. Waltonen, MD; C.A. Sullivan, MD; R. Rouchard-Plasser, PA-C; M..., Multidisciplinary Head and Neck Symposium, 1/1/2014
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: